Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations

Archives of Internal Medicine

Volumn 164, Issue 17, 2004, Pages 1881-1887

  Halbert, Chanita Hughes ^a,b   Lynch, Henry ^c   Lynch, Jane ^c   Main, David ^d   Kucharski, Susan ^a   Rustgi, Anil K ^b   Lerman, Caryn ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DP Clinical Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER EPIDEMIOLOGY; CANCER SCREENING; COHORT ANALYSIS; COLON CANCER; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADULT; AGED; COLONIC NEOPLASMS; COLONOSCOPY; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; FEMALE; FOLLOW-UP STUDIES; GENETIC SCREENING; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PROSPECTIVE STUDIES;

EID: 4644239263     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.164.17.1881     Document Type: Article

References (49)

1. Lynch HT, Smyrk TC. Classification of familial adenomatous polyposis: a diagnostic nightmare [editorial]. Am J Hum Genet. 1998;62:1288-1289.
2. Lynch HT, de la Chapelle A. Genetic susceptibility to non-polyposis colorecta cancer. J Med Genet. 1999;36:801-818.
3. Lynch J. The genetics and natural history of hereditary colon cancer. Semin Oncol Nurs. 1997;13:91-98.
4. Aaltonen LA, Salovaara R, Kristo P, et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med. 1998;338:1481-1487.
5. Salovaara R, Loukola A, Kristo P, et al. Population-based molecular detecion of hereditary nonpolyposis colorectal cancer. J Clin Oncol. 2000;18:2193-2200.
6. Lynch PM, Lynch HT, Harris RE. Hereditary proximal colonic cancer. Dis Color Rectum. 1977;20:661-668.
7. Lynch HT, Krush AJ, Larsen AL. Heredity and multiple primary malignant neoplasms: six cancer families. Am J Med Sci. 1967;254:322-329.
8. Watson P, Lynch HT. The tumor spectrum in HNPCC. Anticancer Res. 1994;14:1635-1639.
9. Aarnio M, Sankila R, Pukkala E, et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer. 1999;81:214-218.
10. Fusaro RM, Lynch HT, Pester J, Lynch PM. Torre's syndrome as phenotypic expression of cancer family syndrome [letter]. Arch Dermatol. 1980;116:986-987.
11. Lynch HT, Lynch PM, Pester JA, Fusaro RM. Sebaceous neoplasia and visceral cancer (Torre's syndrome) and its relationship to the cancer family syndrome. In: Lynch HT, Fusaro RM, eds. Cancer-Associated Genodermatoses. New York, NY: Van Nostrand Reinhold; 1982:366-393.
12. Lynch HT, Fusaro RM, Roberts L, Voorhees GJ, Lynch JF. Muir-Torre syndrome in several members of a family with a variant of the cancer family syndrome. Br J Dermatol. 1985;113:295-301.
13. Lynch HT, Fusaro RM. Muir-Torre syndrome: heterogeneity, natural history, diagnosis, and management. Probl Gen Surg. 1993;10:1-14.
14. Lynch HT, Leibowitz R, Smyrk T, et al. Colorectal cancer and the Muir-Torre syndrome in a Gypsy family: a review. Am J Gastroenterol. 1999;94:575-580.
15. Peltomaki P, Aaltonen LA, Sistonen P, et al. Genetic mapping of a locus predisposing to human colorectal cancer. Science. 1993;260:810-812.
16. Fusaro RM, Lemon SJ, Lynch HT. The Muir-Torre syndrome: a variant of hereditary nonpolyposis colorectal cancer syndrome. J Tumor Marker Oncol. 1996;11:19-31.
17. Lindblom A, Tannergard P, Werelius B, Nordenskjold M. Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer. Nat Genet. 1993;5:279-282.
18. Nystrom-Lahti M, Parsons R, Sistonen P, et al. Mismatch repair genes on chromosomes 2p and 3p account for a major share of hereditary nonpolyposis colorectal cancer families evaluable by linkage. Am J Hum Genet. 1994;55:659-665.
19. Nicolaides NC, Papadopoulos N, Liu B, et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature. 1994;371:75-80.
20. Chung DC, Rustgi AK. The hereditary nonpolyposis colorectal cancer syndrome: genetics and clinical implications. Ann Intern Med. 2003;138:560-570.
21. Markowitz AJ, Winawer SJ. Screening and surveillance for colorectal cancer. Semin Oncol. 1999;26:485-498.
22. Vasen HF, Nagengast FM, Khan PM. Interval cancers in hereditary nonpolyposis colorectal cancer (Lynch syndrome). Lancet. 1995;345:1183-1184.
23. Burke W, Petersen G, Lynch P, et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer: hereditary nonpolyposis colon cancer. JAMA. 1997;277:915-919.
24. Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale: update based on new evidence. Gastroenterology. 2003;124:544-560.
25. Vasen HF, van Ballegooijen M, Buskens E, et al. A cost-effectiveness analysis of colorectal screening of hereditary nonpolyposis colorectal carcinoma gene carriers. Cancer. 1998;82:1632-1637.
26. Jarvinen HJ, Mecklin JP, Sistonen P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology. 1995;108:1405-1411.
27. Jarvinen HJ, Aarnio M, Mustonen H, et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology. 2000;118:829-834.
28. Renkonen-Sinisalo L, Aarnio M, Mecklin JP, Jarvinen HJ. Surveillance improves survival of colorectal cancer in patients with hereditary nonpolyposis colorectal cancer. Cancer Detect Prev. 2000;24:137-142.
29. Lerman C, Hughes C, Track BJ, et al. Genetic testing in families with hereditary nonpolyposis colon cancer. JAMA. 1999;281:1618-1622.
30. Aktan-Collan K, Mecklin JP, Jarvinen H, et al. Predictive genetic testing for hereditary non-polyposis colorectal cancer: uptake and long-term satisfaction. Int J Cancer. 2000;89:44-50.
31. Lynch HT, Watson P, Shaw TG, et al. Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer, II: hereditary non-polyposis colorectal carcinoma as a model. Cancer. 1999;86(suppl):2457-2463.
32. Vernon SW, Myers RE, Tilley BC. Development and validation of an instrument to measure factors related to colorectal cancer screening adherence. Cancer Epidemiol Biomarkers Prev. 1997;6:825-832,
33. Myers RE, Vernon SW, Tilley BC, Lu M, Watts BG. Intention to screen for colorectal cancer among white male employees. Prev Med. 1998;27:279-287.
34. Division of Adult and Community Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System Online Prevalence Data. 1995-2002. Available at: http://apps.nccd.cdc.gov/brfss/index.asp. Accessed September 17, 2003.
35. Codori AM, Petersen GM, Miglioretti DL, Boyd P. Health beliefs and endoscopic screening for colorectal cancer: potential for cancer prevention. Prev Med. 2001;33:128-136.
36. Michie S, Smith JA, Senior V, Marteau TM. Understanding why negative genetic test results sometimes fail to reassure. Am J Med Genet. 2003;119A:340-347.
37. Watson P, Lin KM, Rodriguez-Bigas MA, et al. Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members. Cancer. 1998;83:259-266.
38. Lanspa SJ, Jenkins JX, Cavalieri RJ, et al. Surveillance in Lynch syndrome: how aggressive? Am J Gastroenterol. 1994;89:1978-1980.
39. Jass JR, Stewart SM. Evolution of hereditary non-polyposis colorectal cancer. Gut. 1992;33:783-786.
40. Vasen HF, Taal BG, Nagengast FM, et al. Hereditary nonpolyposis colorectal cancer: results of long-term surveillance in 50 families. Eur J Cancer. 1995;31A:1145-1148.
41. American Society of Clinical Oncology. Policy update on genetic testing for cancer susceptibility. J Clin Oncol. 2003;21:2397-2406.
42. Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) [congresses]. Dis Colon Rectum. 1991;34:424-425.
43. Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC [congresses]. Gastroenterology. 1999;116:1453-1456.
44. Rodriguez-Bigas MA, Boland CR, Hamilton SR, et al. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines [congresses]. J Natl Cancer Inst. 1997;89:1758-1762.
45. Batra S, Valdimarsdottir H, McGovern M, et al. Awareness of genetic testing for colorectal cancer predisposition among specialists in gastroenterology. Am J Gastroenterol. 2002;97:729-733.
46. Schroy PC, Barrison AF, Ling BS, et al. Family history and colorectal cancer screening: a survey of physician knowledge and practice patterns. Am J Gastroenterol. 2002;97:1031-1036.
47. Gordon NP, Hiatt RA, Lampert DI. Concordance of self-reported data and medical record audit for six cancer screening procedures. J Natl Cancer Inst. 1993;85:566-570.
48. Baier M, Calonge N, Cutter G, et al. Validity of self-reported colorectal cancer screening behavior. Cancer Epidemiol Biomarkers Prev. 2000;9:229-232.
49. Wagner A, Tops C, Wijnen JT, et al. Genetic testing in hereditary non-polyposis colorectal cancer families with a MSH2, MLH1, or MSH6 mutation [letter]. J Med Genet. 2002;39:833-837.